# Usefulness of Ultrasound-derived Fat Fraction for Quantification of Hepatic Steatosis in Patients Suspected of MASLD

> **NCT06662851** · — · ACTIVE_NOT_RECRUITING · sponsor: **So Yeon Kim** · enrollment: 150 (estimated)

## Conditions studied

- MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

## Interventions

- **DIAGNOSTIC_TEST:** UDFF

## Key facts

- **NCT ID:** NCT06662851
- **Lead sponsor:** So Yeon Kim
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-27
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-08-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06662851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06662851, "Usefulness of Ultrasound-derived Fat Fraction for Quantification of Hepatic Steatosis in Patients Suspected of MASLD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06662851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*